E/M Coding Alert - 2005 Issue 15
Drug Payments: Drugs In Doctors' Offices Will Stay Under Part B
Subscribe or sign in to view the full article.
Article Overview
This article reviews a CMS report on how physician-administered drugs may be treated under Medicare’s new prescription drug benefit. It explains the broad policy reasons CMS gives for keeping most office-based drugs in Part B, notes that a limited subset may warrant further study, and highlights why the issue matters for physicians, office billing teams, and drug plan sponsors.
Why This Topic Matters
The topic affects how physician offices handle Medicare drug reimbursement, patient cost-sharing, and administrative workflow. It is relevant to practices that administer drugs in the office and to readers tracking Medicare Part B and Part D policy changes.
What You Will Learn
- How CMS is evaluating the placement of physician-office drugs under Medicare benefits
- Why the article frames the issue as important for office-based billing and administration
- What kinds of operational concerns are raised when considering a shift in coverage structure
- How Medicare policy changes can affect physician practices and drug plan administration
Who Should Read This
- Physicians
- Medical office billing staff
- Coders
- Practice managers
- Oncology practices
- Medicare policy readers
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com